PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
103 hedge funds and large institutions have $138M invested in Aratana Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $161M → $138M (-$22.5M)
29% less call options, than puts
Call options by funds: $110K | Put options by funds: $154K
Holders
103
Holding in Top 10
1
Calls
$110K
Puts
$154K
Top Buyers
| 1 | +$8.82M | |
| 2 | +$3.21M | |
| 3 | +$2.2M | |
| 4 |
Goldman Sachs
New York
|
+$2.14M |
| 5 |
Renaissance Technologies
New York
|
+$2.02M |
Top Sellers
| 1 | -$9.47M | |
| 2 | -$7.18M | |
| 3 | -$3.81M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$329K |
| 5 |
EMG
Ellington Management Group
Old Greenwich,
Connecticut
|
-$304K |